pSivida Corp. Stock Nasdaq

Stocks

16-08-09	PSivida : Primary Endpoint Met in pSivida's Utilization Study of New Medidur™ Inserter with Smaller Diameter Needle	PU
16-07-14	PSivida : Investigator-Sponsored Phase 2 Study Results Show pSivida's Medidur® Fully Controlled Uveitis for Two Years with No Recurrence of Disease While Visual Acuity Continued to Improve	PU
16-05-02	PSivida : Medidur for Posterior Uveitis Granted Orphan Drug Designation in Europe	PU
15-09-28	PSivida : Announces NDA for Medidur™ Now Planned Using Six-Month Efficacy Data from Both Phase III Trials; FDA Concurs	BU
15-09-14	PSivida : CEO to Present at Ladenburg Thalmann 2015 Healthcare Conference September 29, 2015	BU

1 day

-0.87%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PSIVIDA CORP.	-0.87%	-2.40%	-	-	0
ARGENX SE	-0.38%	+0.40%	+71.69%	+128.83%	56.71B
WUXI APPTEC CO., LTD.	+4.91%	-3.30%	+71.97%	+92.14%	51.3B
INSMED INCORPORATED	+1.48%	+10.52%	+23.01%	+495.47%	25.26B
BIONTECH SE	-0.59%	-1.00%	-16.73%	-12.99%	23.65B
WUXI BIOLOGICS (CAYMAN) INC.	+3.93%	+7.11%	+44.20%	-1.96%	18.69B
GENMAB A/S	+2.01%	+7.22%	+41.55%	-24.93%	17.71B
PHARMAESSENTIA CORPORATION	-6.84%	+4.81%	+201.88%	+348.11%	17.7B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-0.92%	+8.90%	+38.48%	-	14.26B
EXELIXIS, INC.	+1.76%	+5.82%	+31.23%	+195.70%	14.1B
Average	+0.45%	+3.45%	+56.37%	+152.55%	26.6B
Weighted average by Cap.	+1.06%	+2.16%	+58.77%	+145.18%

Employees

Sector